Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × WW Domain-Containing Oxidoreductase × Clear all

NCT00051974 2008-02-11

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung